Mobile Devices
From Apps to BYOD
Mobile technology, from smartphones and tablets to other connected devices, improves patient engagement, data collection, and remote monitoring.
BYOD solutions improve patient retention by enabling the use of their own, as opposed to provisioned, devices. It propels the ability to conduct DCTs successfully.
Mobile technology is core to DCTs which often rely on the use of mobile apps for patient-reported outcomes (PROs) and electronic patient-reported outcomes (ePROs).
Apps allow patients to conveniently report symptoms, side effects, and information about their condition and treatment.
Designing Mobile Tech the Right Way
Apps and a BYOD approach can not only enhance patient experience and adherence but also improve the accuracy and completeness of the data collected.
Mobile technology helps track symptoms, vital signs, and other health data, which are transmitted to the study team in real time, enabling remote monitoring and improving patient safety.
In order to collect high-quality data, mobile devices and apps must be reliable and accurate and data being collected must be consistent across different devices. Technical support can be difficult for a disparate and wide range of devices.
Making Mobile Technology Work
Leveraging its eSource technology and leadership in digital biomarkers, Clinical ink is leading the way to realizing the full potential of mobile technology.
Apps Powered by eSource
One integrated patient experience.
One single app to run all study activities.
Ensured patient data security and privacy.
Increased trial efficiency and cost-effectiveness.
Fostered communication between patients and study teams.
Deployment in multiple modalities and cross-platform (Android / iOS).
Reduced complexity for patients and improve adherence.
UX research and testing to ensure seamless patient experience.
